StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Stock Performance NBY opened at $0.68 on Thursday. The firm’s fifty day moving average is $1.12 and its two-hundred day […]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Rating) shares hit a new 52-week high on Friday . The stock traded as high as $10.06 and last traded at $10.06, with a volume of 635541 shares. The stock had previously closed at $9.13. Analysts Set New Price Targets A number of research firms have recently issued reports […]
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a report published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CTIC. Needham & Company LLC cut CTI BioPharma from a buy rating to a hold […]
StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Stock Performance NYSEAMERICAN NBY opened at $0.68 on Tuesday. The company has a market capitalization of $1.27 million, a price-to-earnings ratio of […]
StockNews.com initiated coverage on shares of BioLineRx (NASDAQ:BLRX – Get Rating) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating on shares of BioLineRx in a report on Wednesday, March 22nd. BioLineRx Stock Up 5.0 % BLRX stock opened […]